ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Copenhagen-based biotechnology firm Commit Biologics closed a 60 million dollar seed financing round led by Ackermans & van Haaren on November 17, 2026. The company plans to use funds for IND-enabling activities for COM002 and advancing a second program. New investors include AbbVie Ventures and M Ventures, while existing backers Bioqube Ventures, Korys and Novo Holdings participated.
Tap to vote and see what everyone thinks.
Summary by ByteBrief